136 related articles for article (PubMed ID: 31236817)
21. Processing of nimesulide-PEG 400-PG-PVP solid dispersions: preparation, characterization, and in vitro dissolution.
Gohel MC; Patel LD
Drug Dev Ind Pharm; 2003 Mar; 29(3):299-310. PubMed ID: 12741611
[TBL] [Abstract][Full Text] [Related]
22. The roles of a surfactant in zein-HPMC blend solid dispersions for improving drug delivery.
Ngo HV; Tran PHL; Lee BJ; Tran TTD
Int J Pharm; 2019 May; 563():169-173. PubMed ID: 30954672
[TBL] [Abstract][Full Text] [Related]
23. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
25. Role of Surfactant Micellization for Enhanced Dissolution of Poorly Water-Soluble Cilostazol Using Poloxamer 407-Based Solid Dispersion via the Anti-Solvent Method.
Jin G; Ngo HV; Cui JH; Wang J; Park C; Lee BJ
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063136
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of lyophilized cefpodoxime proxetil-Pluronic
Yurtdaş-Kırımlıoğlu G
Pharm Dev Technol; 2021 Apr; 26(4):476-489. PubMed ID: 33616480
[TBL] [Abstract][Full Text] [Related]
28. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.
Pongpeerapat A; Wanawongthai C; Tozuka Y; Moribe K; Yamamoto K
Int J Pharm; 2008 Mar; 352(1-2):309-16. PubMed ID: 18162340
[TBL] [Abstract][Full Text] [Related]
29. Influence of polyvinylpyrrolidone quantity on the solubility, crystallinity and oral bioavailability of fenofibrate in solvent-evaporated microspheres.
Yousaf AM; Kim DW; Kim DS; Kim JO; Youn YS; Cho KH; Yong CS; Choi HG
J Microencapsul; 2016 Jun; 33(4):365-71. PubMed ID: 27283260
[TBL] [Abstract][Full Text] [Related]
30. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
31. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
32. Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR.
Pongpeerapat A; Higashi K; Tozuka Y; Moribe K; Yamamoto K
Pharm Res; 2006 Nov; 23(11):2566-74. PubMed ID: 16969700
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
[TBL] [Abstract][Full Text] [Related]
34. Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug-Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate.
Guo Y; Mishra MK; Wang C; Sun CC
Mol Pharm; 2020 Feb; 17(2):579-587. PubMed ID: 31829631
[TBL] [Abstract][Full Text] [Related]
35. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
36. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
[TBL] [Abstract][Full Text] [Related]
37. Effect of the Interaction Between an Ionic Surfactant and Polymer on the Dissolution of a Poorly Soluble Drug.
Parikh V; Gumaste SG; Phadke S
AAPS PharmSciTech; 2018 Oct; 19(7):3040-3047. PubMed ID: 30084069
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of fast dissolving ibuprofen-polyethylene glycol 6000 solid dispersions.
Newa M; Bhandari KH; Kim JA; Yoo BK; Choi HG; Yong CS; Woo JS; Lyoo WS
Drug Deliv; 2008 Aug; 15(6):355-64. PubMed ID: 18686079
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
Wei JD; Ho HO; Chen CH; Ke WT; Chen ET; Sheu MT
J Pharm Pharmacol; 2010 Dec; 62(12):1685-96. PubMed ID: 21054394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
